Cetera Advisor Networks LLC Has $251,000 Position in iRhythm Technologies, Inc. (NASDAQ:IRTC)


Share on StockTwits

Cetera Advisor Networks LLC increased its stake in iRhythm Technologies, Inc. (NASDAQ:IRTC) by 14.6% in the 4th quarter, Holdings Channel reports. The firm owned 1,058 shares of the company’s stock after purchasing an additional 135 shares during the period. Cetera Advisor Networks LLC’s holdings in iRhythm Technologies were worth $251,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently bought and sold shares of IRTC. Amundi Pioneer Asset Management Inc. acquired a new position in shares of iRhythm Technologies during the first quarter worth approximately $1,911,000. LPL Financial LLC acquired a new stake in shares of iRhythm Technologies in the third quarter worth $479,000. Great West Life Assurance Co. Can grew its stake in shares of iRhythm Technologies by 308.5% in the third quarter. Great West Life Assurance Co. Can now owns 8,056 shares of the company’s stock worth $478,000 after acquiring an additional 6,084 shares during the last quarter. UBS Asset Management Americas Inc. grew its stake in shares of iRhythm Technologies by 2.8% in the third quarter. UBS Asset Management Americas Inc. now owns 30,633 shares of the company’s stock worth $7,294,000 after acquiring an additional 848 shares during the last quarter. Finally, Truist Financial Corp acquired a new stake in shares of iRhythm Technologies in the third quarter worth $291,000.

Shares of NASDAQ IRTC opened at $128.88 on Thursday. The stock has a market cap of $3.76 billion, a PE ratio of -67.48 and a beta of 1.68. The business has a fifty day moving average of $144.76 and a two-hundred day moving average of $204.29. iRhythm Technologies, Inc. has a 52-week low of $75.53 and a 52-week high of $286.19. The company has a debt-to-equity ratio of 0.07, a quick ratio of 6.46 and a current ratio of 6.55.

iRhythm Technologies (NASDAQ:IRTC) last issued its quarterly earnings data on Thursday, February 25th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.31) by ($0.02). iRhythm Technologies had a negative net margin of 20.97% and a negative return on equity of 28.89%. Analysts predict that iRhythm Technologies, Inc. will post -1.56 earnings per share for the current year.

In other iRhythm Technologies news, EVP David A. Vort sold 5,000 shares of iRhythm Technologies stock in a transaction on Tuesday, January 19th. The stock was sold at an average price of $251.37, for a total transaction of $1,256,850.00. Following the completion of the transaction, the executive vice president now directly owns 28,542 shares of the company’s stock, valued at $7,174,602.54. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last three months, insiders have sold 15,000 shares of company stock valued at $3,648,050. Company insiders own 3.10% of the company’s stock.

IRTC has been the topic of several research analyst reports. William Blair restated a “buy” rating on shares of iRhythm Technologies in a research note on Thursday, December 10th. Robert W. Baird restated a “hold” rating on shares of iRhythm Technologies in a research note on Sunday, February 28th. Morgan Stanley raised their price objective on shares of iRhythm Technologies from $227.00 to $288.00 and gave the stock an “overweight” rating in a research note on Monday, January 25th. BTIG Research decreased their price target on shares of iRhythm Technologies from $283.00 to $210.00 and set a “buy” rating on the stock in a research note on Thursday, February 4th. Finally, Truist decreased their price target on shares of iRhythm Technologies from $265.00 to $220.00 in a research note on Monday, February 1st. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and seven have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $214.54.

About iRhythm Technologies

iRhythm Technologies, Inc, a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias.

Further Reading: How can investors invest in the S&P/TSX Index?

Want to see what other hedge funds are holding IRTC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iRhythm Technologies, Inc. (NASDAQ:IRTC).

Institutional Ownership by Quarter for iRhythm Technologies (NASDAQ:IRTC)

Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.